吸气努力影响机械通气伴自主呼吸活动患者脉压变异度预测容量反应性的准确性:一项前瞻性队列研究
本研究为在大学医院ICU开展的前瞻性队列研究,纳入189例接受容量控制通气且伴自主呼吸活动的急性循环衰竭患者,在补液试验前后进行血流动力学测量,以P0.1和全呼吸气道闭合压变化(ΔPocc)评估吸气努力,以心输出量增加≥10%定义容量反应者。53例(28.0%)为容量反应者。全体人群中PPV>9.5%预测容量反应性的AUROC为0.79(0.67–0.83)。按P0.1中位数分层后PPV预测性能差异显著:P0.1<1.5 cmH2O组AUROC为0.90(0.82–0.99),P0.1≥1.5 cmH2O组为0.68(0.57–0.79)(p=0.0016);按ΔPocc中位数分层则无显著差异。P0.1<1.5 cmH2O组灰区为10.5–11.5%,P0.1≥1.5 cmH2O组为8.5–16.5%。
要点
- 容量控制通气伴自主呼吸活动的急性循环衰竭患者中,P0.1<1.5 cmH2O时PPV预测容量反应性的AUROC为0.90(0.82–0.99),切点为10.5%。
- P0.1≥1.5 cmH2O时PPV预测容量反应性的AUROC仅0.68(0.57–0.79),切点为9.5%,灰区宽达8.5–16.5%。
- 按P0.1中位数分层后PPV预测性能差异有统计学意义(p=0.0016),按ΔPocc中位数(−9.8 cmH2O)分层则无显著差异。
- 全体人群中PPV>9.5%预测容量反应性的AUROC为0.79(0.67–0.83)。
- 189例中53例(28.0%)为容量反应者(心输出量增加≥10%)。
适用人群与场景
- 大学医院ICU中接受容量控制通气且伴自主呼吸活动的急性循环衰竭患者,共纳入189例。
诊断标准与关键阈值
- 容量反应者定义:补液试验后心输出量增加≥10%。
- 吸气努力分层:P0.1<1.5 cmH2O与P0.1≥1.5 cmH2O;ΔPocc<−9.8 cmH2O与ΔPocc≥−9.8 cmH2O(按中位数分层)。
- PPV预测容量反应性的切点:全体人群>9.5%;P0.1<1.5 cmH2O组为10.5%;P0.1≥1.5 cmH2O组为9.5%。
- 灰区:P0.1<1.5 cmH2O组为10.5–11.5%;P0.1≥1.5 cmH2O组为8.5–16.5%。
研究设计与关键结果
- 研究类型:前瞻性队列研究,单中心(大学医院ICU),纳入189例接受容量控制通气伴自主呼吸活动的急性循环衰竭患者,补液试验前后测量血流动力学,以P0.1和ΔPocc评估吸气努力。
- 主要终点:全体人群中PPV>9.5%预测容量反应性的AUROC为0.79(0.67–0.83);53例(28.0%)为容量反应者。
- 按P0.1中位数分层后PPV预测性能差异显著(p=0.0016):P0.1<1.5 cmH2O组AUROC为0.90(0.82–0.99),P0.1≥1.5 cmH2O组为0.68(0.57–0.79);切点分别为10.5%和9.5%。
- 按ΔPocc中位数(−9.8 cmH2O)分层后PPV预测性能无显著差异。
- 灰区:P0.1<1.5 cmH2O组为10.5–11.5%,P0.1≥1.5 cmH2O组为8.5–16.5%。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在容量控制通气伴自主呼吸活动的急性循环衰竭患者中,当P0.1<1.5 cmH2O时PPV预测容量反应性较可靠(AUROC 0.90,灰区10.5–11.5%);P0.1≥1.5 cmH2O时PPV预测性能下降(AUROC 0.68,灰区8.5–16.5%)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Pulse pressure variation (PPV) is unreliable in predicting fluid responsiveness (FR) in patients receiving mechanical ventilation with spontaneous breathing activity. Whether PPV can be valuable for predicting FR in patients with low inspiratory effort is unknown. We aimed to investigate whether PPV can be valuable in patients with low inspiratory effort.
METHODS: This prospective study was conducted in an intensive care unit at a university hospital and included acute circulatory failure patients receiving volume-controlled ventilation with spontaneous breathing activity. Hemodynamic measurements were collected before and after a fluid challenge. The degree of inspiratory effort was assessed using airway occlusion pressure (P0.1) and airway pressure swing during a whole breath occlusion (ΔPocc) before fluid challenge. Patients were classified as fluid responders if their cardiac output increased by ≥ 10%. Areas under receiver operating characteristic (AUROC) curves and gray zone approach were used to assess the predictive performance of PPV.
RESULTS: Among the 189 included patients, 53 (28.0%) were defined as responders. A PPV > 9.5% enabled to predict FR with an AUROC of 0.79 (0.67-0.83) in the whole population. The predictive performance of PPV differed significantly in groups stratified by the median value of P0.1 (P0.1 < 1.5 cmH2O and P0.1 ≥ 1.5 cmH2O), but not in groups stratified by the median value of ΔPocc (ΔPocc < - 9.8 cmH2O and ΔPocc ≥ - 9.8 cmH2O). Specifically, in patients with P0.1 < 1.5 cmH2O, PPV was associated with an AUROC of 0.90 (0.82-0.99) compared with 0.68 (0.57-0.79) otherwise (p = 0.0016). The cut-off values of PPV were 10.5% and 9.5%, respectively. Besides, patients with P0.1 < 1.5 cmH2O had a narrow gray zone (10.5-11.5%) compared to patients with P0.1 ≥ 1.5 cmH2O (8.5-16.5%).
CONCLUSIONS: PPV is reliable in predicting FR in patients who received controlled ventilation with low spontaneous effort, defined as P0.1 < 1.5 cmH2O. Trial registration NCT04802668. Registered 6 February 2021, https://clinicaltrials.gov/ct2/show/record/NCT04802668.
参考来源
- Chen H, Liang M, He Y, et al. Inspiratory effort impacts the accuracy of pulse pressure variations for fluid responsiveness prediction in mechanically ventilated patients with spontaneous breathing activity: a prospective cohort study. Ann Intensive Care. 2023. PMID: 37592166. doi:10.1186/s13613-023-01167-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。